javeri fiscal logo
Home SiteMap ContactUs
javeri fiscal services Ltd
IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
Avience Biomedicals Ltd.
Issue Open Date 18-Jun-26  
Issue Closing Date 22-Jun-26  
Application Money 100  
Allotment Money  
Price Band 196 - 208  
Minimium Application No. 1200  
Issue Size (Shares) 1044000  
Market Lot 1.00  
Objective
1. Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh2. Funding the Working Capital Requirement of our Company3. To meet out the General Corporate Purposes
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors     123709800   NA  
Qualified Institutional Buyers     53837400   NA  
Retail Individual Investors     193132800   NA  
Business Description
Avience Biomedicals Limited is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) productsand medical devices in Noida, Uttar Pradesh, India. In vitro diagnostics (IVDs) are tests that can detect disease, conditions andinfections
more...
Promoter's Holding
Total Share Capital   3742885  
Offered to Public   1044000  
Promoter's Holding (Pre-Issue)   92.85  
Promoter's Holding (Post-Issue)   64.59  
Address
C-11
Block- C
Community Centre
Janakpuri A-3
New Delhi ,
Delhi ,
110058
Phone: 011-45699388
Email: info@avienbio.com
Website: www.avienbio.com
Registrar
Skyline Financial Services Pvt Ltd
123
Vinoba Puri
Lajpat Nagar - II

New Delhi
Listed at
NSE
Lead Manager
Fintellectual Corporate Advisors Pvt Ltd.
Promoters
Deepa Choudhary
Dharam Deo Choudhary
Janardan Pal
Ram Nagina Choudhary
Back Back TopTop
kyc form Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Scores| Policies of JFSL
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE| Rights and obligation| SARAL Form
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.